Cardiovascular Devices are used in treating diseases related to the heart and the circulatory system. Cardiac Rhythm Management Devices (CRM) devices are those devices that are used to restore the natural synchronized pumping rhythm of the heart. A Pacemaker is a device designed to regulate cardiac rhythm through the delivery of electrical impulses via electrodes that interface directly with the myocardial tissue. GlobalData uses proprietary data and analytics to provide a comprehensive report on the pacemakers devices market, including market shares of different players within South Korea. Buy the latest report here.
Smarter leaders trust GlobalData
In 2023, GlobalData’s Market Model methodology determined that the leading player in the pacemakers market in South Korea was Abbott Laboratories followed by Medtronic, Boston Scientific, Biotronik SE and MicroPort Scientific.
A Pacemaker can be a Single Chamber or Dual Chamber type. Single Chamber Pacemakers with leads are devices that have a single pacing lead placed into a chamber of the heart. Dual Chamber Pacemakers have pacing leads placed in two chambers of the heart.
The value of the pacemakers devices market within South Korea was expected to be over $10m in 2023.
For the latest complete market share analysis of pacemakers device market in South Korea, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
